24 LIfesciences trend

  According to a newly published market research report by 24LifeSciences , global veterinary orthopedic implants market was valued at USD 150 million in 2024  and is projected to reach USD 309 million by 2031 , growing at a compound annual growth rate (CAGR) of 11.2% during the forecast period 2025–2031 . Veterinary orthopedic implants are critical medical devices designed to repair fractures, stabilize joints, and facilitate bone healing in companion and large animals. These implants, primarily manufactured from high-grade stainless steel and titanium alloys , include plates, screws, pins, wires, staples, and joint replacement systems . Advanced plastic coatings often act as artificial cartilage surfaces. The fundamental surgical procedure, internal fixation , relies on these implants to restore mobility and improve the quality of life for animals suffering from traumatic injuries, degenerative conditions, or congenital defects. Download a Free Sample Report (PDF):...

  According to a newly published market research report by 24LifeSciences , global disposable cortical electrodes market was valued at USD 288 million in 2024 and is projected to reach USD 611 million by 2031 , growing at a compound annual growth rate (CAGR) of 11.2% during the forecast period. Disposable cortical electrodes are sophisticated medical devices specifically engineered for single-use applications in neurological monitoring and diagnostics. These electrodes are positioned directly onto the brain's cortical surface during surgical procedures to record intricate electrical activity, which is indispensable for mapping eloquent functional areas and guiding complex neurosurgical interventions. Manufactured from biocompatible materials such as platinum, iridium, and stainless steel, these electrodes come in various configurations including strip, grid, and depth designs to accommodate the diverse requirements of different neurological procedures. The market's robust ...

  According to a newly published market research report by 24LifeSciences , global doxycycline hyclate oral capsules market was valued at USD 481 million in 2024  and is projected to reach USD 662 million by 2031 , growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2025–2031 . Doxycycline hyclate, a semi-synthetic tetracycline-class antibiotic, is widely prescribed for its broad-spectrum efficacy against a diverse range of bacterial infections, including respiratory infections, sexually transmitted diseases like chlamydia, acne vulgaris, urinary tract infections, Lyme disease, and certain parasitic infections . Its bacteriostatic action, which inhibits protein synthesis in susceptible bacteria, along with its favorable pharmacokinetic profile, continues to make it a cornerstone therapy in both clinical and outpatient settings globally. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/3962/doxycyclin...

  According to a newly published market research report by 24LifeSciences , global antipyretic drugs for pregnant women market was valued at USD 474 million in 2024  and is projected to reach USD 560 million by 2031 , growing at a compound annual growth rate (CAGR) of 1.6% during the forecast period 2025-2031 . Antipyretic drugs for pregnant women are medications specifically evaluated for relative safety during pregnancy, primarily used to reduce fever and alleviate discomfort. Maternal fever poses significant risks to fetal development , including potential neural tube defects and preterm birth, making safe fever management critically important. The market is dominated by acetaminophen (paracetamol) , which remains the first-line recommended therapy due to its extensive safety profile. While growth is modest, it reflects the essential nature of this specialized segment and its stability amid broader economic fluctuations. Download a Free Sample Report (PDF):  http...

  According to a newly published market research report by 24LifeSciences , global dry eye diagnosis systems market was valued at USD 277 million in 2024  and is projected to reach USD 431 million by 2031 , growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period. Dry eye diagnosis systems are sophisticated medical devices specifically engineered to assess and diagnose dry eye syndrome, a prevalent ocular condition characterized by either insufficient tear production or poor tear quality that leads to ocular surface inflammation and damage. These advanced systems utilize a range of precise techniques to evaluate tear film stability, osmolarity, meibomian gland function, and overall ocular surface health with exceptional accuracy and reliability, enabling clinicians to move beyond subjective symptom assessment toward objective, data-driven diagnosis and personalized treatment planning. Download a Free Sample Report (PDF):  https://www.24lifescie...